BridgeBio Gets US Approval for Heart Drug to Compete with Pfizer
BridgeBio Pharma Inc. gained US approval for a drug to treat a progressive and deadly form of heart disease, paving the way ...
Johnson threatens legal action to get COVID-19 vaccine data
U.S. Sen. Ron Johnson has threatened to issue a subpoena when he becomes chairman of the Permanent Subcommittee on ...
STAT18h
More beef in the gene editing space
In today's biotech news, Prime Editing's CEO promises aggressive defense of patents; Novartis acquires a gene editing startup ...
EconoTimes18h
CDC Reveals Alarming COVID Vaccine Update: 'Fewer Than 18% of Adults Are Getting the Shot'
Fewer than 18% of U.S. adults have opted to receive the newly updated COVID-19 vaccine, according to the latest data from the ...
Moderna's Fresh Blow As RFK Heads To HHS - A Tough 2025 May Be In Store
Moderna, Inc.'s stock plummets as challenges mount, including vaccine skepticism, competitive pressures, and the RFK ...
Pfizer Stock Drops 10% In November On News Of Kennedy's HHS Nomination
Pfizer shares are trading lower by 10% in November. President-elect Donald Trump last week announced his intention to nominate Robert F. Kennedy Jr. to lead the HHS.
FiercePharma21h
As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing pact
For Big Pharma, recent headlines out of China suggest multinational drugmakers are facing their share of challenges in the ...
Medscape21h
As GLP-1 Use Surges, Clinicians Weigh Benefits and Risks
GLP-1 RAs to assist with weight loss have exploded in popularity. Researchers are working to identify which patients will ...